Showing results (81-90 of 858) with videos related to
Sort By:
Pageof 86
Disability and Rehabilitation|March 27, 2023
Factors influencing the willingness to adopt telerehabilitation among rehabilitation professionals in Austria and Germany: a survey comparing data before and during COVID-19Barbara Seebacher, Elena Bergmann, Carole Geimer, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2014
Antibody responses following induction of antigen-specific tolerance with antigen-coupled cellsPatrick Peschl, Markus Reindl, Kathrin Schanda, et al.Archives of Neurology|February 29, 2012
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritisKevin Rostasy, Simone Mader, Kathrin Schanda, et al.Frontiers in Immunology|June 29, 2023
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serumKlaus Berek, Angelika Bauer, Dagmar Rudzki, et al.Journal of Neuroimmunology|October 7, 2015
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trialRainer Ehling, Franziska Di Pauli, Peter Lackner, et al.The American Journal of Pathology|August 2, 2011
Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neuronsNadia Stefanova, Lisa Fellner, Markus Reindl, et al.Plos One|June 1, 2011
Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotectionSylvia Stemberger, Angelika Jamnig, Nadia Stefanova, et al.Plos One|November 19, 2011
Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitisKarin Steinbach, Claire L McDonald, Markus Reindl, et al.Children (Basel, Switzerland)|May 1, 2025
The Presence of MRZ Reactions Improves the Prediction of Multiple Sclerosis in Children with Optic NeuritisFranziska Kauth, Sophie Chen, Eva-Maria Wendel, et al.Journal of Neuroinflammation|October 27, 2017
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelinationPatrick Peschl, Kathrin Schanda, Bleranda Zeka, et al.Pageof 86